Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Determinants of mean arterial pressure and pulse pressure in chronic haemodialysis patients

Journal of Human Hypertension volume 15, pages 775–779 (2001)Cite this article

Abstract

Hypertension is highly prevalent in the dialysis population, and has been implicated in the pathogenesis of the observed excess of cardiovascular morbidity and mortality in these patients. Nevertheless, there are no reports on the clinical and biochemical determinants of both pulse pressure (PP) and mean arterial pressure (MAP) in dialysis populations. A total of 541 haemodialysed patients from 11 dialysis centres were included in the study. The demographic, clinical, and biological characteristics were recorded. Both pre- and post- dialytic blood pressures (systolic and diastolic) were measured. PP and MAP were calculated. Mean predialytic PP was 67 ± 17 mm Hg and significantly decreased after dialysis (60 ± 18 mm Hg; P < 0.0001). In multivariate analysis, a 10 mm Hg increase in PP was positively associated with age (RR, 2.01; 95% CI, 1.35–5.01, for a 10-year increase in age), diabetes mellitus (RR, 1.08; 95% CI, 1.04–1.14), interdialytic weight gain (IWG) (RR, 1.84; 95% CI, 1.07–3.18, for 1% increase in IWG), and current smoking (RR, 2.59; 95% CI, 1.13–5.92) and negatively with Hb concentration (RR, 0.92; 95% CI, 0.84–0.99, for a 1 g/100 ml in Hb). Mean predialytic MAP was 98 ± 15 mm Hg and significantly decreased after dialysis (91 ± 16 mm Hg; P < 0.0001). In multivariate analysis, a 10 mm Hg increase in MAP was positively associated with parathyroid hormone (PTH) (RR, 1.32; 95% CI, 1.15–1.6, for 50 ng/ml in PTH), erythropoietin (EPO) treatment (RR, 1.09; 95% CI, 1.03–1.16), and current smoking (RR, 1.87; 95% CI, 1.39–2.41). PP and MAP are associated with different clinical parameters. Most of these factors are potentially reversible. Smoking cessation, correction of anaemia and limitation of IWG should be important challenges for physicians in care of dialysis patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. US Renal Data System: USRDS Annual Data Report, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases 1997

  2. US Department of Health and Human Services: Morbidity and Mortality: Chartbook on Cardiovascular, Lung, and Blood Diseases, Bethesda, MD, US Department of Health and Human Services 1996

  3. Foley RN, Parfrey PS, Sarnak MJ Clinical epidemiology of cardiovascular disease in chronic renal disease Am J Kidney Dis 1998 32 (Suppl 3) 112–119

    Article  Google Scholar 

  4. Rahman M, Fu P, Sehgal AR, Smith MC Interdialytic weight gain, compliance with dialysis regimen, and age are independent predictors of blood pressure in hemodialysispatients Am J Kidney Dis 2000 35 257–65

    Article  CAS  PubMed  Google Scholar 

  5. Foley RN et alImpact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease Kidney Int 1996 49 1379–1385

    Article  CAS  PubMed  Google Scholar 

  6. Zager PG et al‘U’ curve association of blood pressure and mortality in hemodialysispatients Kidney Int 1998 54 561–569

    Article  CAS  PubMed  Google Scholar 

  7. O’Rourke MF Arterial function in health and disease Churchill Livingstone: Edinburgh, UK 1982

    Google Scholar 

  8. Nichols WW, Nicolini FA, Pepine CJ Determinants of isolated systolic hypertension in the elderly J Hypertens 1992 10 (Suppl 6) S73–S77

    Google Scholar 

  9. Franklin S Ageing and hypertension: the assessment of blood pressure indices in predicting coronary heart disease risk J Hypertens 1999 17 (Suppl 5) S29–S36

    Google Scholar 

  10. London GM et alCardiac and arterial interactions in end-stage renal disease Kidney Int 1996 50 600–608

    Article  CAS  PubMed  Google Scholar 

  11. Whelton PK Blood pressure in adults and the elderly. In: Bulpitt CJ (ed) Handbook of Hypertension. Vol 6 Elsevier: Amsterdam 1985 pp 51–69

    Google Scholar 

  12. Nichols WW, Avolio AP, Kelly RP, O’Rourke MF Effects of age and of hypertension on wave travel and reflections. In: O’Rourke MF, Safar M, Dzau V (eds). Arterial Vasodilation. Mechanisms and Therapy Lea & Febiger: Philadelphia 1993

    Google Scholar 

  13. O’Rourke MF Arterial stiffness, systolic blood pressure and logical treatment of arterial hypertension Hypertension 1990 15 339–347

    Article  PubMed  Google Scholar 

  14. Omvik P How smoking affects blood pressure Blood Pres 1996 5 71–77

    Article  CAS  Google Scholar 

  15. McNagny SE, Ahluwalia JS, Clark WS, Resnicow KA Cigarette smoking and severe uncontrolled hypertension in inner-city African Americans Am J Med 1997 103 121–127

    Article  CAS  PubMed  Google Scholar 

  16. Swislocki AL et alSmokeless nicotine administration is associated with hypertension but not with a deterioration in glucose tolerance in rats Metabolism 1997 46 1008–1012

    Article  CAS  PubMed  Google Scholar 

  17. Cryer PE, Haymond MW, Santiago JV, Shah SD Norepinephrine and epinephrine release and adrenergic medication of smoking associated hemodynamic and metabolic events N Engl J Med 1976 295 573–577

    Article  CAS  PubMed  Google Scholar 

  18. Nadler JL, Velasco JS, Horton R Cigarette smoking inhibits prostacyclin formation Lancet 1983 1 1248–1250

    Article  CAS  PubMed  Google Scholar 

  19. Welnnalm A et alRelation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men Circulation 1991 83 1698–1704

    Article  Google Scholar 

  20. Celermajer D, Sorensen KE, Georgakopoulos D Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilatation in healthy young adults Circulation 1993 88 2149–2155

    Article  CAS  PubMed  Google Scholar 

  21. Kiowski W, Linder L, Stoschitzsky K Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothlin-1 in clinically healthy smokers Circulation 1994 90 27–34

    Article  CAS  PubMed  Google Scholar 

  22. Haak T, Jungmann E, Raab C, Usadel KH Elevated endothelin-1 levels after cigarette smoking Metabolism 1994 43 267–269

    Article  CAS  PubMed  Google Scholar 

  23. Coomer RW, Schulman G, Breyer JA, Shyr Y Ambulatory blood pressure monitoring in dialysispatients and estimation of mean interdialytic blood pressure Am J Kidney Dis 1997 29 678–684

    Article  CAS  PubMed  Google Scholar 

  24. Conion PJ Predialysis systolic blood pressure correlates strongly with mean 24 hour systolic blood pressure and left ventricular mass in stable hemodialysispatients J Am Soc Nephrol 1996 7 2658–2663

    CAS  PubMed  Google Scholar 

  25. Salem MM, Davis M Effect of one year of hemodialysis on weight and blood pressure in 434patients Artif Organs 1997 21 402–404

    CAS  PubMed  Google Scholar 

  26. Cheigh JS et alHypertension is not adequately controlled in hemodialysispatients Am J Kidney Dis 1992 19 453–459

    Article  CAS  PubMed  Google Scholar 

  27. Dionisio P et alInfluence of the hydration state on blood pressure values in a group ofpatients on regular maintenance hemodialysis Blood Purif 1997 15 25–33

    Article  CAS  PubMed  Google Scholar 

  28. Goldsmith DJ, Covic AC, Venning MC, Ackrill P Ambulatory blood pressure monitoring in renal dialysis and transplantpatients Am J Kidney Dis 1997 29 593–600

    Article  CAS  PubMed  Google Scholar 

  29. Raine AE et alHyperparathyroidism, platelet intracellular free calcium and hypertension in chronic renal failure Kidney Int 1993 43 700–705

    Article  CAS  PubMed  Google Scholar 

  30. Goldsmith DJA, Covic AA, Venning MC, Ackrill P Blood pressure reduction after parathyroidectomy for secondary hyperparathyroidism: further evidence implicating calcium homeostasis in blood pressure regulation Am J Kidney Dis 1996 27 819–825

    Article  CAS  PubMed  Google Scholar 

  31. Eschbach JW et alRecombinant human erythropoietin in anemicpatients with end-stage renal disease Ann Int Med 1989 111 992–1000

    Article  CAS  PubMed  Google Scholar 

  32. Sundal E, Kaeser U Correction of anemia of chronic renal failure with recombinant human erythropoietin: safety and efficacy of one year’s treatment in a European multicenter study of 150 haemodialysis-dependentpatients Nephrol Dial Transplant 1989 4 979–987

    Article  CAS  PubMed  Google Scholar 

  33. Canadian Erythropoietin Study Group Association between recombinant erythropoietin and quality of life and exercise capacity ofpatients receiving hemodialysis Br Med J 1990 300 573–578

    Article  Google Scholar 

  34. Heidenreich S, Rahn K-H, Zidek W Direct vasopressor effect of recombinant human erythropoietin on renal resistance vessels Kidney Int 1991 39 259–265

    Article  CAS  PubMed  Google Scholar 

  35. Bode-Böger SM et alEndothelin release and shift of prostaglandin balance are involved in the modulation of vascular tone by recombinant erythropoietin J Cardiovasc Pharmacol 1992 20 (Suppl 12) S25–S28

    Article  Google Scholar 

  36. Bode-Böger SM et alRecombinant human erythropoietin enhances vasoconstrictor tone via endothelin-& and constrictor prostanoids Kidney Int 1996 50 1255–1261

    Article  PubMed  Google Scholar 

  37. Carlini RG et alRecombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells Kidney Int 1993 43 1010–1014

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nephrology, Dialysis, and Renal Transplantation, Saint Jacques Hospital, Besançon, France

    AB Abdelfatah, G Motte, D Ducloux & JM Chalopin

Authors
  1. AB Abdelfatah
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G Motte
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D Ducloux
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. JM Chalopin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D Ducloux.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abdelfatah, A., Motte, G., Ducloux, D. et al. Determinants of mean arterial pressure and pulse pressure in chronic haemodialysis patients. J Hum Hypertens 15, 775–779 (2001). https://doi.org/10.1038/sj.jhh.1001273

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001273

Keywords

This article is cited by

Search

Advanced search

Quick links